We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Qualcomm-NXP Merger Back on Track After Trump's ZTE Push
Read MoreHide Full Article
In a dramatic turn of events, regulators of China have reportedly restarted the review process for the proposed merger of Qualcomm Incorporated (QCOM - Free Report) with NXP Semiconductors N.V. (NXPI - Free Report) that was long shelved. The strategic move is expected to ease the trade relationship between the United States and China that seemed to be on the boil due to various restrictions and counter restrictions imposed on each other.
The top administration of China has asked its Ministry of Commerce officials to fast track the review process that was put on hold when domestic companies raised objections to the deal. They argued that the transaction was a potent threat to their survival as the combined entity would extend Qualcomm’s patent licensing business into areas like mobile payments and autonomous driving. The issue became a bone of contention between the two warring countries as China being the largest importer of semiconductors, was aggressively trying to end its dependence on the United States and gain an upper hand.
The issue further spiraled into a full-fledged conflict when the U.S. government banned sale of components by American firms to Chinese telecom equipment maker, ZTE Corp. Citing a breach of an agreement inked last year, the U.S. Department of Commerce slapped a seven-year ban on sale of various components to ZTE after it was caught illegally shipping goods to Iran. This crippled the operations of ZTE and threatened its survival to such an extent that the Chinese officials were forced to make solemn representations to the visiting U.S. delegates to convey its plight. ZTE also formally appealed to the U.S. Commerce Department's Bureau of Industry and Security to suspend the ban on its products.
Although President Trump refused to budge initially, he made a sudden turnabout by acknowledging in a Twitter post that he was working with the Chinese President Xi Jinping to give ZTE “a way to get back into business, fast.” This perhaps tilted the scales in favor of Qualcomm and set the ball rolling to get the approval for its merger with NXP. The transaction, when complete, will position Qualcomm as a strong player in the next-generation mobile chipset segment with a potential market size of $138 billion by 2020.
Qualcomm has underperformed the industry in the past three months with an average loss of 15.4% compared with a decline of 3.3% for the latter. Whether a core business focus can indeed help the company to turn the tables and improve its sagging shares remains to be seen.
Motorola has an expected long-term earnings growth rate of 8%. It exceeded estimates in each of the trailing four quarters with an average beat of 12.1%.
PCTEL has exceeded estimates twice in the trailing four quarters with an average beat of 17.9%.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Qualcomm-NXP Merger Back on Track After Trump's ZTE Push
In a dramatic turn of events, regulators of China have reportedly restarted the review process for the proposed merger of Qualcomm Incorporated (QCOM - Free Report) with NXP Semiconductors N.V. (NXPI - Free Report) that was long shelved. The strategic move is expected to ease the trade relationship between the United States and China that seemed to be on the boil due to various restrictions and counter restrictions imposed on each other.
The top administration of China has asked its Ministry of Commerce officials to fast track the review process that was put on hold when domestic companies raised objections to the deal. They argued that the transaction was a potent threat to their survival as the combined entity would extend Qualcomm’s patent licensing business into areas like mobile payments and autonomous driving. The issue became a bone of contention between the two warring countries as China being the largest importer of semiconductors, was aggressively trying to end its dependence on the United States and gain an upper hand.
The issue further spiraled into a full-fledged conflict when the U.S. government banned sale of components by American firms to Chinese telecom equipment maker, ZTE Corp. Citing a breach of an agreement inked last year, the U.S. Department of Commerce slapped a seven-year ban on sale of various components to ZTE after it was caught illegally shipping goods to Iran. This crippled the operations of ZTE and threatened its survival to such an extent that the Chinese officials were forced to make solemn representations to the visiting U.S. delegates to convey its plight. ZTE also formally appealed to the U.S. Commerce Department's Bureau of Industry and Security to suspend the ban on its products.
Although President Trump refused to budge initially, he made a sudden turnabout by acknowledging in a Twitter post that he was working with the Chinese President Xi Jinping to give ZTE “a way to get back into business, fast.” This perhaps tilted the scales in favor of Qualcomm and set the ball rolling to get the approval for its merger with NXP. The transaction, when complete, will position Qualcomm as a strong player in the next-generation mobile chipset segment with a potential market size of $138 billion by 2020.
Qualcomm has underperformed the industry in the past three months with an average loss of 15.4% compared with a decline of 3.3% for the latter. Whether a core business focus can indeed help the company to turn the tables and improve its sagging shares remains to be seen.
Qualcomm currently has a Zacks Rank #3 (Hold). Better-ranked stocks in the industry include Motorola Solutions, Inc. (MSI - Free Report) and PCTEL, Inc. , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Motorola has an expected long-term earnings growth rate of 8%. It exceeded estimates in each of the trailing four quarters with an average beat of 12.1%.
PCTEL has exceeded estimates twice in the trailing four quarters with an average beat of 17.9%.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>